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Abstract The postmortem diagnosis of heat-related deaths
presents certain difficulties. Firstly, preterminal or terminal
body temperatures are often not available. Additionally,
macroscopic and microscopic findings are nonspecific or
inconclusive and depend on survival duration after expo-
sure. The diagnosis of hyperthermia is therefore essentially
based on scene investigation, the circumstances of death,
and the reasonable exclusion of other causes of death. Im-
munohistochemistry and postmortem biochemical investi-
gations have been performed by several authors in order to
better circumstantiate the physiopathology of hyperthermia
and provide further information to confirm or exclude a
heat-related cause of death. Biochemical markers, such as
electrolytes, hormones, blood proteins, enzymes, and neuro-
transmitters, have been analyzed in blood and other biological
fluids to improve the diagnostic potential of autopsy, histology,
and immunohistochemistry. The aim of this article is to present
a review of the medicolegal literature pertaining to the post-
mortem biochemical investigations that are associated with
heat-related deaths.
Keywords Hyperthermia .Forensicpathology .Postmortem
diagnosis . Postmortem biochemistry
Introduction
Hyperthermia is clinically diagnosed by a core temperature
>40 °C (104 °F), occurring when the body's thermoregula-
tory mechanisms are no longer capable of effectively dissi-
pating heat. Hyperthermia is distinguished from fever and
hyperpyrexia which characteristically occur with an increased
hypothalamic set point due to severe infection or central
nervous system hemorrhages.
Hyperthermia is more often observed in the summer
months in particularly hot environments and is more common
in the very young and the elderly as well as those presenting
severe preexisting medical conditions [1, 2]. Indeed, a signif-
icant number of heat-related deaths occurring during a heat
wave do not result solely from hyperthermia but from heat
stress, which fatally exacerbates any important, underlying
medical disease [3–8].
The elderly, children, and those suffering from cardiovas-
cular disease are at greater risk of heat-related death. Predis-
posing factors that may limit the body's ability to emplace an
effective thermoregulatory response to excessive heat include
dementia, psychiatric illnesses, diabetes, hyperthyroidism,
obesity, burns, alcohol consumption, and chronic alcohol mis-
use. These conditions complicate the usual dissipation of heat
due to increased metabolism, decreased activity, increased
subcutaneous fat, or the inability to peripherally vasodilate,
sweat properly, and release excessive heat [1, 2, 9, 10].
Bunai et al. [11] described a case of fatal hyperthermia
that occurred in a 39-year-old man with a body mass index
of 31.4 and a state of excited delirium during a police arrest.
Siegler [12] reported a case of fatal heat stroke in a young
woman with previously undiagnosed Hashimoto's thyroid-
itis. According to the author, in conditions of high temper-
ature, hypothyroid patients continue to conserve heat or
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have attenuated heat loss rather than heat dissipation through
sweating. Moreover, the decreased adrenergic activity in hy-
pothyroidism would lead to decreased cardiac output, again
interfering with effective heat loss.
Dementia and psychiatric illnesses can also compromise
the body's ability to adequately react to a hot environment.
Hyperthermia (exertional heat stroke) can also be fatal in
people participating in strenuous outdoor physical activities
in hot weather (e.g., athletes, military personnel, and workers)
and especially in people with severe, preexisting medical
conditions [13–26]. Voluntary exposure to extreme dry or
humid heat may result in illness or even death by heat stroke
and/or dehydration [27].
Social and environmental factors, such as self-care incom-
petence and social isolation, may predispose some people to
fatal hyperthermia. Infants and young children are more sus-
ceptible to developing hyperthermia from a hot environment
given their reduced sweating capacity, higher metabolic rate,
greater heat vulnerability, and larger body surface-to-volume
ratio than adults [1, 2].
Most heat-related deaths are due to weather conditions.
Hyperthermia deaths in children younger than 4 years of age
often coincide with vehicular entrapment on warm days.
Death can occur in a relatively short amount of time in these
cases [28–40]. Only a small percentage of heat-related deaths
are of man-made origin (e.g., in boiler rooms, furnaces,
vehicles, or factory-generated extreme heat conditions or elec-
trical appliance misuse) [41–43].
Various classes of licit and illicit drugs can increase the risk
of developing fatal hyperthermia. Drugs with anticholinergic
side effects (e.g., tricyclic antidepressants, antihistamines,
antiparkinsonians, and antipsychotics) impair the sweating
mechanism and hinder the body's ability to eliminate heat
properly. The diuretics often used by the elderly cause volume
depletion, thereby limiting the body's ability to increase car-
diac output and perspire [1, 2].
Mild to severe hyperthermia may be associated with recre-
ational or pharmaceutical sympathomimetic drug use. Am-
phetamine and methamphetamine augment the release of
norepinephrine, dopamine, and serotonin from presynaptic
nerve terminals and inhibit the synaptic uptake. Some amphet-
amine metabolites inhibit monoamine oxidase. Although
structurally dissimilar, the clinical effects of amphetamine
and methamphetamine are nearly identical to cocaine. The
central thermoregulatory disturbances from sympathomimetic
drugs arise from complex interactions between dopamine and
serotonin in the brain stem and hypothalamus and can result in
an increased rate of metabolism and core temperature. Periph-
erally, sympathomimetics disrupt temperature homeostasis by
several pathways and can result in the vasoconstriction of
peripheral vessels and impaired heat dissipation [44].
Neuroleptic malignant syndrome (NMS) is a rare but poten-
tially life-threatening side effect of psychotropic medications
that have antidopaminergic action. NMS may be generated by
either an idiosyncratic response to dopamine antagonists or by
dopamine agonist withdrawal. The predictive signs of NMS
have historically included muscular rigidity and changes
in mental status, followed by hyperthermia (temperature
>105 °F) and autonomic instability. The pathophysiological
mechanism of NMS is thought to involve the blockage of
dopaminergic transmission in the nigrostriatal pathway [45–51].
Malignant hyperthermia (MH) is a skeletal muscle phar-
macogenetic disorder characterized by a hypermetabolic re-
sponse to potent, volatile anesthetic gases, such as halothane,
sevoflurane, and desflurane, as well as to the depolarizing
muscle relaxant succinylcholine. The body's reactions to these
drugs are dominated by progressive hyperthermia, hence the
name. The triggering agents cause an increase in the concen-
tration of free cytoplasmic calcium, which is released from the
sarcoplasmic reticulum stores via the muscle ryanodine recep-
tor. The ryanodine receptor (RYR1) gene encodes the key
channel that mediates the calcium release in skeletal muscle
during excitation–contraction coupling. Mutations in the rya-
nodine receptor gene are attributed to approximately 50 % of
patients susceptible to MH [52–55].
Serotonin syndrome is a condition characterized by cen-
tral serotonin hyperstimulation. Classic findings of severe
serotonin syndrome include hyperthermia, mental status
changes, autonomic instability, and altered muscle tone or
rigidity. A number of medications have been implicated in
the induction of serotonin syndrome, including those that
reduce metabolism (e.g., monoamine oxidase inhibitors),
increase production (e.g., L-tryptophan), or inhibit serotonin
uptake (e.g., fluoxetine, clomipramine, meperidine, dextro-
methorphan, pentazocine, and fenfluramine). The complica-
tions resulting from hyperthermia associated with severe
serotonin syndromemay include rhabdomyolysis, cardiac dys-
rhythmias, renal failure, disseminated intravascular coagula-
tion, seizures, coma, and death [56–60].
The postmortem diagnosis of heat-related death presents
certain difficulties. Although people dying of hyperthermia
can have body temperatures >40.6 °C (105 °F), in routine
forensic pathology, preterminal or terminal body temperatures
are often not available. Autopsy findings may be minimal and
difficult to interpret, especially if bodies have reached ad-
vanced stages of decomposition in a hot environment. Thus,
the diagnosis of hyperthermia is mainly based on scene inves-
tigation and the circumstances of death [1, 2, 61].
One significant difficulty faced by forensic pathologists
in the past was the lack of uniform diagnostic criteria for
heat-related deaths. In response to this problem, the National
Association of Medical Examiners' Ad Hoc Committee on
the Definition of Heat-Related Fatalities recommended that
a death be designated as heat related if exposure to high
ambient temperature either caused or significantly contrib-
uted to death. The committee also recommended that the
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diagnosis of heat-related death be based on a history of
exposure to high environmental temperature as determined
by investigation and the reasonable exclusion of other causes
of death.
Heat-related death should be listed as a possible cause of
death or at least a significant contributing condition when
the antemortem body temperature at the time of death can-
not be established and the circumstances of the death sug-
gest hyperthermia. A heat-related cause of death may
furthermore be assumed if the investigation provides com-
pelling evidence of continuous exposure to a hot environ-
ment and fails to identify an independent cause of death.
The collection of blood, urine, vitreous humor, and other
biological fluids for toxicological and biochemical investi-
gations is strongly suggested since autopsy findings in heat-
related deaths are nonspecific. Nonetheless, a diagnosis of
heat-related death is still principally based on investigative
information [61, 62].
Autopsy, histology, and immunohistochemistry
Necropsy findings in cases of fatal heat stroke are nonspe-
cific and depend on the survival duration after exposure.
Tissue damage is caused by several mechanisms including
ischemia as a result of massive blood shunting away from
the internal organs to the skin. When victims of heat stroke
survive <12 h, the only abnormalities noted may be petechial
or larger hemorrhages in the skin with slippage or petechial
hemorrhages over the surface of the lungs, heart, and serosal
surfaces. Pulmonary and cerebral edema with diffuse neuronal
injury may be observed following longer periods of survival
[1, 10, 42, 61, 63].
Right-sided cardiac dilatation, subendocardial hemorrhage
of the left ventricle, visceral congestion (particularly in the
lungs and the brain), and petechial hemorrhages in the thy-
mus, the perifollicular area of the spleen, and lymph nodes
have also been described in people who died shortly after the
onset of heat stress [11, 43]. Tissue damage may be revealed
by centrilobular necrosis and midzonal vacuolar changes in
the liver, neuronal degeneration of the brain, and acute pan-
creatitis. Rhabdomyolysis may result in acute tubular necrosis
of the kidneys. Should disseminated intravascular coagulation
occur, fibrin thrombi may appear in small blood vessels [61].
Other microscopic findings, such as pulmonary fat emboliza-
tion, have also been described [64].
Fineschi et al. [42] studied the tissue expression of the heat
shock proteins HSP 70, 27, and 90 in a case of heat stroke
involving an infant who died in an incubator. They found that
the expression of these proteins was increased in the epitheli-
um of the trachea and in the skin.
Quan et al. [65] observed high ubiquitin immunoreactivity
in the midbrain periaqueductal gray matter in cases of
hyperthermia and hypothesized that the neuronal ubiquitina-
tion may be a finding of nonspecific neurodegeneration as a
consequence of metabolic disorders or central nervous system
dysfunction, depending on the survival time. Ishikawa et al.
[66] found low myoglobin and ubiquitin immunopositivity in
the renal tubular epithelium cells of hyperthermia fatalities
and postulated that this result may be attributed to advanced
renal tubular damage (despite advanced skeletal muscle dam-
age) and the downregulation of ubiquitin-dependent protein
degradation, as previously suggested by Smith et al. [67]. A
markedly low pituitary adrenocorticotropic hormone (ACTH)
immunopositivity in hyperthermia cases has been described
by Ishikawa et al. [68], which was likely related to multiple
organ dysfunction. The same authors also observed [69] a
significantly decreased rate of neuronal dopamine immuno-
positivity in the hypothalamus and increased noradrenaline
and dopamine immunopositivity rates in the adrenal medulla.
According to the authors, these findings suggested that there
was a terminal hyperfunction of the sympathetic/adrenome-
dullary system involving the adrenal medulla in fatal hyper-
thermia. They concluded that noradrenaline and dopamine
immunopositivity in the adrenal medulla may be used as
markers to investigate the magnitude of the physical stress
responses involving the sympathetic/adrenomedullary system
in the hyperthermia death process. Conversely, the lower rate
of neuronal dopamine immunopositivity in the hypothalamus
in hyperthermia could indicate a dysfunction of the central
nervous system, which appeared to be independent of the
activation of the sympathetic/adrenomedullary system, as
demonstrated by increased serum and cerebrospinal fluid
(CSF) catecholamine levels. According to the authors, such
hypothalamic dysfunction could lead to deterioration of the
hypothalamic–pituitary–adrenal stress response system, hence
concluding that the hypothalamic neuronal dopamine immu-
nopositivity might be used as a marker to investigate the
function of the hypothalamic–pituitary–adrenal axis. Finally,
Yoshida et al. [70] described a high hypothalamic neuronal
chromogranin A (CgA) immunopositivity in hyperthermia
cases, together with no increase in CgA immunopositivity in
the adrenal medulla.
Postmortem biochemistry
Electrolytes
The physiopathology of hyperthermia as a consequence of heat
stroke typically involves dehydration and electrolyte distur-
bance [1, 71]. Abnormalities in antemortem serum sodium
concentrations are traditionally considered as reflected in post-
mortem vitreous humor values, making it possible to diagnose
hypo- or hypernatremia at the time of death. Similar to sodium,
vitreous chloride concentrations have been determined to be
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relatively stable during the early postmortem period, and ab-
normalities in antemortem serum chloride are thought to be
reflected in postmortem vitreous values [72–80]. In a study
performed on 385 medicolegal autopsy cases, Li et al. [81]
analyzed postmortem calcium and magnesium levels in peri-
cardial fluid. When compared with other studied groups, hy-
perthermia cases had lower calcium concentrations, likely
related to skeletal muscle damage, higher magnesium levels,
and higher Mg/Ca ratios.
Catecholamines
Kortelainen et al. [82] investigated urinary catecholamine
levels in five hyperthermia cases (four of them under the
influence of ethanol) and compared these values with those
from a control group of five sudden violent deaths. The
authors observed increased urinary noradrenaline levels in
hyperthermia victims, whereas adrenaline and dopamine con-
centrations were not significantly different between the two
groups. The authors assumed that high postmortem urinary
noradrenaline levels in hyperthermia victims could represent a
sign of sympathetic hyperactivity following heat exposure.
Thus, they concluded that urinary noradrenaline levels could
be used as a biochemical marker in investigations of hyper-
thermia fatalities. Zhu et al. [83] analyzed catecholamine
levels (adrenaline, noradrenaline, and dopamine) in 542 fo-
rensic autopsy cases in postmortem serum from different
sampling sites (left and right heart chambers, and subclavian
and external iliac vein). The characteristic findings of hyper-
thermia fatalities were higher dopamine levels in both cardiac
and peripheral blood, accompanied by significantly higher
adrenaline and noradrenaline levels in external iliac venous
blood. According to the authors, these findings suggested that
postmortem serum catecholamine levels reflected the magni-
tude of physical stress responses during the death process in
individual cases.
In a successive study, Ishikawa et al. [69] observed
elevated serum and CSF catecholamine levels in hyperther-
mia cases, together with a lower neuronal dopamine immu-
nopositivity in the hypothalamus. According to the authors,
these findings suggested a dysfunction of the hypothalamus
in hyperthermia fatalities, which appeared to be independent
of the activation of the sympathetic/adrenomedullary sys-
tem, as shown by the increased serum and CSF catechol-
amine levels.
Pituitary hormones
Ishikawa et al. [68, 84] investigated ACTH and growth
hormone (GH) levels in postmortem serum from right heart
blood and CSF in two series of forensic autopsies including
hyperthermia fatalities. In an initial study performed on
162 forensic autopsies [68], the authors observed that
hyperthermia cases presented postmortem serum and CSF
ACTH levels that were significantly lower than reference
values and concentrations found in other studied groups, in
which CSF levels were usually much higher than the post-
mortem serum levels. Additionally, serum and CSF ACTH
levels were significantly correlated. Hyperthermia fatalities
also displayed a lower CSF/serum ratio and a markedly low
pituitary ACTH immunopositivity, which was likely related
to multiple organ dysfunction due to hyperthermia. In a
successive study performed on 116 forensic autopsies that
focused on postmortem serum and CSF GH levels and
pituitary GH immunopositivity [84], hyperthermia fatalities
did not display peculiar changes, also suggesting that the
postmortem serum and CSF GH and ACTH levels behave
differently based on the varied stress reactions of the hypo-
thalamic–pituitary–adrenal axis.
Markers of renal function
Zhu et al. [85–87] analyzed urea nitrogen, creatinine, and
uric acid levels in pericardial fluid and postmortem serum
from different sampling sites (right heart, left heart, subcla-
vian vein, and external iliac vein). In an initial study [85]
performed on 395 medicolegal autopsy cases, heat stroke
fatalities displayed increased postmortem serum creatinine
levels along with normal urea nitrogen concentrations,
which was likely related to skeletal muscle damage due to
hyperthermia. These findings, together with the fact that
myoglobinuria was often observed in cases of death by heat
stroke, suggested that the elevation of postmortem serum
creatinine levels was caused by mild muscle damage that
was antecedent to myoglobinemia and myoglobinuria. In
another study [86] performed on 409 medicolegal autopsy
cases, the authors examined urea nitrogen, creatinine, and
uric acid pericardial fluid levels. Hyperthermia cases pre-
sented mild increases in urea nitrogen concentrations, mild
to moderate elevations in creatinine values, a low urea
nitrogen/creatinine ratio (<10), and moderate elevations in
uric acid levels. Lastly, in a third study [87] performed on
556 medicolegal autopsy cases, the authors compared the
differences between pericardial fluid and postmortem serum
levels of urea nitrogen, creatinine, and uric acid. Postmor-
tem serum was obtained from different sampling sites (the
right heart, left heart, and external iliac vein). The authors
observed similar distributions in postmortem serum and
pericardial fluid for all markers in hyperthermia fatalities.
However, some of these cases presented postmortem serum
creatinine levels that were markedly higher than pericardial
fluid levels. Significant changes in pericardial fluid levels
became apparent several hours later than in serum, leading the
authors to conclude that elevations in pericardial fluid urea
nitrogen, creatinine, and/or uric acid levels could suggest
prolonged survival over hours.
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Markers of cardiac function
Zhu et al. [88–91] and Wang et al. [92] investigated a series
of cardiac markers, including atrial natriuretic peptide (ANP),
brain natriuretic peptide (BNP), cardiac troponin T (cTnT),
cardiac troponin I (cTnI), creatine kinase MB (CK-MB), and
myoglobin (Mb) in blood and pericardial and cerebrospinal
fluids. In a study [88] performed on 405 medicolegal autopsy
cases, the authors analyzed cTnT levels in pericardial fluid
and postmortem serum from different sampling sites (right
heart, left heart, and external iliac vein). cTnT levels in post-
mortem serum from heart blood and pericardial fluid were
higher than those in peripheral blood. Furthermore, hyperther-
mia cases had significantly higher postmortem serum cTnT
levels at each site and especially high pericardial fluid cTnT
levels. The morphological severity of myocardial damage was
well correlated with cTnT levels in postmortem serum from
heart blood and pericardial fluid. Thus, cases that showed
diffuse myocardial damage were also characterized by the
highest cTnT levels. Analyses with regard to the time since
death revealed that significantly high cTnT levels were ob-
served in both early (<12 h) and late (12–48 h) postmortem
periods. Finally, comparisons with histopathological findings
suggested that advanced myocardial damage involving swell-
ing and liquefactive necrosis were closely related to increased
cTnT levels. In a study performed on 263 forensic autopsy
cases, Zhu et al. [90] analyzed ANP, BNP, and cTnT pericar-
dial fluid levels. The results of this study revealed that there
was no significant postmortem influence on pericardial ANP
and BNP levels within 72 h after death. Additionally, ANP
and BNP were negatively correlated with cTnT levels in
pericardial fluid, which suggested that their production by
cardiac tissue was reduced depending on the severity of myo-
cardial damage. Hyperthermia fatalities displayed decreased
pericardial ANP and BNP levels. Since previous findings by
the same authors had shown increased postmortem serum and
pericardial cTnT levels in hyperthermia fatalities, the authors
concluded that massive myocardial damage due to advanced
hypoxia was responsible for high cTnT and low ANP and
BNP levels in cases of heat stroke. In a study performed on
234 forensic autopsy cases, the authors [91] investigated
cTnT, cTnI, and CK-MB levels in pericardial fluid and post-
mortem serum from different sampling sites (right heart, left
heart, and external iliac vein). Findings for cTnI were similar
to those for cTnT previously described by the same authors.
cTnI levels in postmortem serum from cardiac blood and
pericardial fluid in hyperthermia cases were relatively high,
whereas cTnI levels were not significant high for postmortem
serum from peripheral blood. Increased cTnI levels in post-
mortem serum from cardiac blood and pericardial fluid were
related to the morphological severity of myocardial damage,
which was due to diffuse liquefactive necrosis, whereas CK-
MB levels were not dependent on the morphological severity
of myocardial damage. Wang et al. [92] investigated CK-MB,
cTnI, andMb levels in pericardial and cerebrospinal fluids and
compared them with those obtained from right heart blood
postmortem serum. The study was performed on 295 forensic
autopsy cases. The authors found that hyperthermia fatalities
were characterized by significantly higher Mb levels in peri-
cardial and cerebrospinal fluids. According to the authors,
these findings indicated that advanced skeletal muscle damage
in fatal hyperthermia affected CSF. Additionally, the results
confirmed the usefulness of combined determinations of bio-
chemical markers in several biological fluids for evaluating
the severity of myocardial and skeletal muscle damage in the
death process.
CgA, serotonin, and S100B
Yoshida et al. [70] investigated CgA and catecholamine
levels in postmortem serum from right heart blood and CSF
of 298 forensic autopsy cases. The authors observed that most
cases of hyperthermia presented higher serum and lower CSF
CgA levels. Additionally, a marked positive correlation be-
tween CgA and catecholamine serum levels was detected for
hyperthermia cases, which also presented a high serum/CSF
CgA ratio and a high hypothalamus neuronal CgA immuno-
positivity, together with no change in CgA immunopositivity
in adrenal medulla. According to the authors, these findings
indicated an activation of the sympathetic/adrenomedullary
system due to hyperthermic stress. However, since no rela-
tionship was detected between serum CgA levels and immu-
nopositivity in adrenal medulla, the authors postulated that
other sources of CgA and catecholamines circulating in blood
could be involved in hyperthermic stress. CgA levels in CSF
were low in hyperthermia cases despite prolonged death ac-
companied by a significant elevation in postmortem serum
CgA levels. According to the authors, this situation could be
interpreted as the consequence of brain dysfunction during
systemic multiple organ failure due to hyperthermia. Hence,
they postulated that CgA may be an independent marker of
lasting stress due to environmental thermal hazards. Quan et
al. [93] investigated serotonin (5-HT) levels in cerebrospinal
and pericardial fluids with regard to the cause of death in 351
medicolegal autopsy cases. The authors observed that hyper-
thermia fatalities presented higher 5-HT levels in both fluids,
suggesting hyperthermic neuronal dysfunction involving se-
rotonin toxicity, which is characterized by neuromuscular
excitation, autonomic stimulation, and an altered mental state.
Li et al. [94] evaluated S100B levels in postmortem serum
from right heart blood and cerebrospinal fluid with regard to
the cause of death in 216 medicolegal autopsy cases. They
observed that S100B levels in CSF were higher in hyperther-
mia cases and proposed a value of 2,000 ng/ml in the early
postmortem period as a biochemical sign of fatally severe
brain damage.
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C-reactive protein and neopterin
Fujita et al. [95] investigated C-reactive protein (CRP) levels
in postmortem serum obtained from right cardiac blood in 408
medicolegal autopsy cases, including 216 cases of acute death
(<30 min) and 192 cases of non-acute death (>30 min). Hy-
perthermia fatalities were classified as non-acute deaths and
short-term survivors (survival time within 6 h) and revealed
low CRP levels (<0.5 mg/dl) when compared with other
causes of death. Maeda et al. [96] analyzed urea nitrogen,
creatinine, and CRP in postmortem serum from the external
iliac vein (or right heart chamber when peripheral blood was
not available) in 429 medicolegal autopsy cases. Most hyper-
thermia fatalities revealed low urea nitrogen and CRP levels
and a markedly increased creatinine value (>2 mg/dl), with
urea nitrogen-to-creatinine ratio significantly lower when
compared with other studied groups that displayed elevated
creatinine levels. The authors concluded that increased post-
mortem serum creatinine levels in hyperthermia fatalities
could be the consequence of mild muscle damage, antecedent
to rhabdomyolysis, or the result of systemic skeletal muscle
damage in advanced multiple organ dysfunction in the ab-
sence of significant inflammation. Ishikawa et al. [97] studied
the concentrations of CRP and neopterin in postmortem serum
from blood obtained from different sampling sites (subclavian
and external iliac veins and left and right heart). The authors
observed low CRP levels (<1 mg/dl) and moderate increases
(50–200 nmol/l) in neopterin concentrations in hyperthermia
fatalities, suggesting that in cases with survival times <24 h,
moderate increases in neopterin levels could be the result of a
rapid activation of macrophages due to tissue injury.
Tryptase
Nishio and Suzuki [98] quantified tryptase values in post-
mortem serum of 122 forensic autopsy cases. In three of them,
the cause of death was attributed to fatal hyperthermia, and
tryptase levels were remarkably increased. Interestingly, one
of these cases had been treated with neuroleptics for several
years and another with clomipramine and fluvoxamine. The
authors postulated that neuroleptic malignant syndrome and
serotonin syndrome could be responsible for these deaths.
Additionally, both cases presented high myoglobin immuno-
reactivity in the renal tubules, which corroborated hyperther-
mia as the cause of death. At the same time, the authors
reported two other cases of hyperthermia that were likely
induced by antidepressant or neuroleptic drugs, without ele-
vation of serum tryptase.
Myoglobin
Zhu et al. [99] investigated urinary Mb levels in 295 forensic
autopsy cases and compared them to postmortem serum
levels. Increased serum Mb values were observed in hyper-
thermia fatalities, which also revealed moderate to high
increases of Mb in urine. However, urinary Mb levels did
not correlate with serum concentrations nor did the severity of
muscle injury. Factors indicated as potentially responsible for
increased urinary Mb levels included autolysis of the bladder
wall muscle tissue 48 h after death and prolonged survival
time associated with hypoxic muscle damage or catabolic
muscle changes. According to the authors, these results sug-
gested that high urinary myoglobin levels in acute and sub-
acute deaths could indicate massive skeletal muscle damage
due to heat stroke.
Procalcitonin
Heat stroke shares clinical similarities with other systemic
inflammatory response syndromes (SIRS), being character-
ized by a wide spectrum of metabolic alterations and multiple
organ failure. In some forms of SIRS, such as burns, severity
and mortality have been clinically predicted by the greatly
increased concentration of circulating procalcitonin (PCT)
[100]. Some clinical studies [100–103] investigated the po-
tential correlation between the presence and course of classic
heat stroke and circulating PCT levels. Nylén et al. [100]
observed significantly increased PCT serum levels in patients
admitted to hospital who survived classic heat stroke. Con-
versely, among those who died, PCT concentrations were not
elevated on admission and failed to increase further, likely
suggesting that more significant increases in body heat or
duration of heat exposure in patients who died may adversely
affect the constitutively secreted PCT or, alternatively, upre-
gulate enzymes that degrade secreted PCT. In a subsequent
study performed by Hausfater et al. [102], PCT serum levels
did not correlate with mortality, and the authors did not
confirm the conclusions of Nylén et al. PCT levels appeared
rather to be an indicator of illness severity and were observed
in cases of heat stroke without any concomitant documented
bacterial infection, suggesting that heat stroke represents a
model of non-septic pathway of PCT synthesis. In agreement
with the conclusions of Hausfater et al., Tong et al. [103]
found that elevated PCT levels in exertional heat stroke did
not indicate concomitant bacterial infections but were instead
associated with the severity of the disease.
Conclusions
The aim of this article was to review the literature pertaining to
biochemical investigations that can be performed in the post-
mortem diagnosis of heat-related fatalities (Table 1). In the
absence of typical morphological findings, such a diagnosis
essentially remains a medley of observations and only the
evidence of exposure to high ambient temperature, as
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determined by investigative information, can provide elucida-
tory elements.
Postmortem examinations are important in order to rule out
other possible causes of death rather than to establish the actual
cause of death. Though the diagnosis of heat-related death
remains principally based on investigative findings, radiology,
autopsy, neuropathology, histology, toxicology, and biochemis-
try should always be carried out to exclude other causes of
death.
Heat stroke is a rare disease in Europe and extensive,
medicolegal studies in this area are not current. Increased
vitreous sodium and chloride, postmortem serum and pericar-
dial fluid creatinine as well as urine myoglobin are the main
biochemical markers that have been traditionally observed in
the postmortem analyses of heat-related fatalities. These find-
ings are the consequences of dehydration and skeletal muscle
damage, distinctive features of heat stroke. Clinically, in-
creased PCT levels have been related to illness severity in the
absence of simultaneously documented bacterial infections.
These analyses should be considered a basic paradigm to
perform when heat-related fatalities are suspected.
Findings concerning other postmortem biochemical markers
can reflect nonspecific situations, such as the magnitude of the
physical stress response and severity of myocardial damage, or
may be the consequence of preexisting diseases. Such results
are not constantly associated with heat-related fatalities and are
thereby of little or no help in such diagnosis.
Another limit of postmortem biochemistry results for the
diagnosis of heat-related fatalities is that most investigations
concerning specific molecules have only been pursued by
certain groups of authors whose results have never been
questioned, validated, confirmed, or invalidated. Furthermore,
some molecules are not routinely investigated in most medi-
colegal centers, so their detection in postmortem biological
fluids is considered an isolated finding at present instead of a
currently available investigation method.
We are of the opinion that the diagnosis of heat-related
fatalities is a medley of investigative and medicolegal obser-
vations and cannot be based on postmortem biochemical
analyses. Moreover, the results of the mentioned biochemical
investigations must necessarily be confirmed by targeted stud-
ies on larger, heat-related death samples. However, within
these limits, postmortem biochemical analyses should be per-
formed in order to improve the quality of forensic autopsies
and create reliable databases. This is particularly necessary in
situations such as classic and exertional heat strokes which are
relatively infrequent in forensic pathology routine and for
which pathognomonic diagnostic elements are currently
unavailable.
Acknowledgments The authors gratefully acknowledge the assistance
of the editors and anonymous reviewers of the journal for their comments
and suggestions on an earlier draft.
References
1. Nixdorf-Miller A, Hunsaker DM, Hunsaker JC 3rd (2006)
Hypothermia and hyperthermia medicolegal investigation of
morbidity and mortality from exposure to environmental temper-
ature extremes. Arch Pathol Lab Med 130:1297–1304
2. Dolinak D, Matshes E, Lew E (2005) Hyperthermia. In: Forensic
pathology. Principles and practice. Elsevier Academic Press, 1 ed.
San Diego pp 247–248
3. Mirchandani HG, McDonald G, Hood IC, Fonseca C (1996)
Heat-related deaths in Philadelphia—1993. Am J Forensic Med
Pathol 17:106–108
4. Semenza JC, Rubin CH, Falter KH, Selanikio JD, Flanders WD,
Howe HL, Wilhelm JL (1996) Heat-related deaths during the July
1995 heat wave in Chicago. N Engl J Med 335:84–90
5. Kaiser R, Rubin CH, Henderson AK, Wolfe MI, Kieszak S,
Parrott CL, Adcock M (2001) Heat-related death and mental
illness during the 1999 Cincinnati heat wave. Am J Forensic
Med Pathol 22:303–307
6. Wolfe MI, Kaiser R, Naughton MP, Mirabelli MC, Yoon SS,
Hanzlick R, Henderson AK (2001) Heat-related mortality in
selected United States cities, summer 1999. Am J Forensic Med
Pathol 22:352–357
7. Naughton MP, Henderson A, Mirabelli MC, Kaiser R, Wilhelm
JL, Kieszak SM, Rubin CH, McGeehin MA (2002) Heat-related
mortality during a 1999 heat wave in Chicago. Am J Prev Med
22:221–227
8. Vandentorren S, Bretin P, Zeghnoun A, Mandereau-Bruno L,
Croisier A, Cochet C, Ribéron J, Siberan I, Declercq B,
Ledrans M (2006) August 2003 heat wave in France: risk factors
for death of elderly people living at home. Eur J Public Health
16:583–591
9. Kortelainen ML (1991) Hyperthermia deaths in Finland in 1970–
86. Am J Forensic Med Pathol 12:115–118
10. Green H, Gilbert J, James R, Byard RW (2001) An analysis of
factors contributing to a series of deaths caused by exposure to
high environmental temperatures. Am J Forensic Med Pathol
22:196–199
11. Bunai Y, Akaza K, Jiang WX, Nagai A (2008) Fatal hyperthermia
associated with excited delirium during an arrest. Led Med
(Tokyo) 10:306–309
12. Siegler RW (1998) Fatal heatstroke in a young woman with
previously undiagnosed Hashimoto's thyroiditis. J Forensic Sci
43:1237–1240
13. Chao TC, Sinniah R, Pakiam JE (1981) Acute heat stroke deaths.
Pathology 13:145–156
14. Assia E, Epstein Y, Shapiro Y (1985) Fatal heatstroke after a short
march at night: a case report. Aviat Space EnvironMed 56:441–442
15. Shapiro Y, Seidman DS (1990) Field and clinical observation of
exertional heat stroke patients. Med Sci Sports Exerc 22:6–14
16. Porter AM (1993) Heat illness and soldiers. Mil Med 158:606–609
17. Hiss J, Kahana T, Kugel C, Epsteil Y (1994) Fatal classic and
exertional heat stroke—report of four cases. Med Sci Law
34:339–343
18. Gardner JW, Kark JA (1994) Fatal rhabdomyolysis presenting as
mild heat illness in military training. Mil Med 159:160–163
19. Kark JA, Burr PQ, Wenger CB, Gastaldo E, Gardner JW (1996)
Exertional heat illness in marine corps recruit training. Aviat
Space Environ Med 67:354–360
20. Gardner JW, Kark JA, Karnei K, Sanborn JS, Gastaldo E, Burr P,
Wenger CB (1996) Risk factors predicting exertional heat illness in
male marine corps recruits. Med Sci Sports Exerc 28:939–944
21. Epstein Y, Moran DS, Shapiro Y, Sohar E, Shemer J (1999)
Exertional heat stroke: a case series. Med Sci Sports Exerc
31:224–228
100 Int J Legal Med (2013) 127:93–102
22. Epstein Y, Shani Y, Moran DS, Shapiro Y (2000) Exertional heat
stroke—the prevention of a medical emergency. J Basic Clin
Physiol Pharmacol 11:395–401
23. Pretzlaff RK (2002) Death of an adolescent athlete with sickle
cell trait caused ba exertional heat stroke. Pediatr Crit Care Med
3:208–210
24. Gardner JW, Gutmann FD, Potter RN, Kark JA (2002)
Nontraumatic exercise-related deaths in the U.S. military,
1996–1999. Mil Med 167:964–970
25. Porter AM (2003) Collapse from exertional heat illness: implica-
tions and subsequent decisions. Mil Med 168:76–81
26. Wallace RF, Kriebel D, Punnett L, Wegman DH, Wenger CB,
Gardner JW, Gonzalez RR (2005) The effects of continuous hot
weather training on risk of exertional heat illness. Med Sci Sports
Exerc 11:263–265
27. Byard RW, Riches KJ (2005) Dehydration and heat-related death:
sweat lodge syndrome. Am J Forensic Med Pathol 26:236–239
28. Roberts KB, Roberts EC (1976) The automobile and heat stress.
Pediatrics 58:101–104
29. Wadlington WB, Tucker AL Jr, Fly F, Greene HL (1976) Heat
stroke in infancy. Am J Dis Child 130:1250–1251
30. Bacon C, Scott D, Jones P (1979) Heatstroke in well-wrapped
infants. Lancet 24:422–425
31. Goodyear JE (1979) Heat hyperpyrexia in an infant (a case
report). Med Sci Law 19:208–209
32. King K, Negus K, Vance JC (1981) Heat stress in motor vehicles:
a problem in infancy. Pediatrics 68:579–582
33. Surpure JS (1982) Heat-related illness and automobile. Ann
Emerg Med 11:263–265
34. Bacon CJ (1983) Over heating in infancy. Arch Dis Child
58:673–674
35. Krous HF, Nadeau JM, Fukumoto RI, Blackbourne BD, Byard RW
(2001) Environmental hyperthermic infant and early childhood
death: circumstances, pathologic changes, and manner of death.
Am J Forensic Med Pathol 22:374–382
36. Schuliar Y, Savourey G, Besnard Y, Launey JC (2001) Diagnosis of
heat stroke in forensic medicine. Contribution of thermophysiology.
Forensic Sci Int 124:205–208
37. McLaren C, Null J, Quinn J (2005) Heat stress from enclosed
vehicles: moderate ambient temperatures cause significant tem-
perature rise in enclosed vehicles. Pediatrics 116:109–112
38. Guard A, Gallagher SS (2005) Heat related deaths to young
children in parked cars: an analysis of 171 fatalities in the
United States, 1995–2002. Inj Prev 11:33–37
39. Booth JN 3rd, Davis GG, Waterbor J, McGwin G Jr (2010)
Hyperthermia deaths among children in parked vehicles: ana
analysis of 231 fatalities in the United States, 1999–2007.
Forensic Sci Med Pathol 6:99–105
40. Grundstein A, Null J, Meentemeyer V (2011) Weather, geography,
and vehicle-related hyperthermia in children. Geogr Rev 101:353–370
41. Ohshima T, Maeda H, Takayasu T, Fujioka Y, Nakaya T (1992)
An autopsy case of infant death due to heat stroke. Am J Forensic
Med Pathol 13:217–221
42. Fineschi V, D'Errico S, Neri M, Pararese F, Ricci PA, Turillazzi E
(2005) Heat stroke in an incubator: an immunohistochemical
study in a fatal case. Int J Legal Med 119:94–97
43. Zhou Y, Li L, Liu L, Jia D, Zhang X, Fowler DR, Xu X (2006)
Heat stroke deaths caused by electric blanket: case report and
review of the literature. Am J Forensic Med Pathol 27:324–327
44. Chan TC, Evans DS, Clark RF (1997) Drug-induced hyperthermia.
Crit Care Clin 13:785–808
45. Lannas PA, Pachar JV (1993) A fatal case of neuroleptic malignant
syndrome. Med Sci Law 33:86–88
46. Fujitani N, Koda Y, Okamura T, Hattori H, Kimura H (2000) A fatal
case of hyperthermia due to tricyclic antipdepressant intoxication.
Leg Med (Tokyo) 2:152–153
47. Stanfield SC, Privette T (2000) Neuroleptic malignant syndrome
associated with olanzapine therapy: a case report. J Emerg Med
19:355–357
48. Kubo S, Orihara Y, Kitamura O, Ikematsu K, Tsuda R, Nakasono
I (2001) An autopsy case of neuroleptic malignant syndrome
(NMS) and its immunohistochemical findings of muscle-
associated proteins and mitochondria. Forensic Sci Int 115:155–
158
49. Hall KL, Taylor WH, Ware MR (2001) Neuroleptic malignant
syndrome due to olanzapine. Psychopharmacol Bull 35:49–54
50. Sheil AT, Collins KA, Schandl CA, Harley RA (2007) Fatal
neurotoxic response to neuroleptic medications. Case report and
review of the literature. Am J Forensic Med Pathol 28:116–120
51. Kemp WL, Fitzgerald J, White CL 3rd (2007) Undiagnosed
progressive supranuclear palsy in a patient with neuroleptic ma-
lignant syndrome due to use of neuroleptics: the utility of autopsy
in deaths due to known drug reactions. Am J Forensic Med Pathol
28:59–62
52. Patil PM (2011) Malignant hyperthermia in the oral and maxillo-
facial surgery patient: un update. Oral Surg Oral Med Oral Pathol
Radiol Endod 11:1–7
53. Ali SZ, Taguchi A, Rosenberg H (2003) Malignant hyperthermia.
Best Pract Res Clin Anaesthesiol 17:519–533
54. Nishio H, Sato T, Fukunishi S, Tamura A, Iwata M, Tsuboi K,
Suzuki K (2009) Identification of malignant hyperthermia-
susceptible ryanodine receptor type 1 gene (RYR1) mutations in
a child who died in a car after exposure to a high environmental
temperature. Leg med (Tokyo) 11:142–143
55. Sato T, Nishio H, Iwata M, Tsuboi K, Tamura A, Miyazaki T,
Suzuki K (2010) Postmortem molecular screening for mutations
in ryanodine receptor type 1 (RYR1) gene in psychiatric patients
suspected of having died of neuroleptical malignant syndrome.
Forensic Sci Int 194:77–79
56. Sternbach H (1991) The serotonin syndrome. Am J Psychiatry
148:705–713
57. Bodner RA, Lynch T, Lewis L, KahnD (1995) Serotonin syndrome.
Neurology 45:219–223
58. Mueller PD, Korey WS (1998) Death by “Ecstasy”: the serotonin
syndrome? Ann Emerg Med 32:377–380
59. Vuori E, Henry JA, Ojanperä I, Nieminen R, Savolainen T,
Wahlsten P, Jäntti M (2003) Death following ingestion of
MDMA (Ecstasy) and moclobemide. Addiction 98:365–368
60. Warrick BJ, Wilson J, Hedge M, Freeman S, Leonard K, Aaron C
(2011) Lethal serotonin syndrome after methylone and butylone
ingestion. J Med Toxicol. doi:10.1007/s13181-011-0199-6
61. Lifschultz BD, Donoghue ER (1998) Forensic pathology of heat-
and cold-related injuries. Clin Lab Med 18:77–90
62. Donoghue ER, Graham MA, Jentzen JM, Lifschutz BD, Luke JL,
Mirchandani HG (1997) Criteria for the diagnosis of heat-related
death: National Association of Medical Examiners. Position pa-
per. National Association of Medical Examiners Ad Hoc
Committee on the definition of heat-related fatalities. Am J
Forensic Med Pathol 18:11–14
63. Sweeney KG (2002) Heat-related deaths. J Insur Med 34:114–
119
64. Inoue H, Ikeda N, Tsuji A, Kudo K, Hanagama M, Nata M (2009)
Pulmonary fat embolization as a diagnostic finding for heat
exposure. Led Med (Tokyo) 11:1–3
65. Quan L, Ishikawa T, Michiue T, Li DR, Zhao D, Zhu BL, Maeda
H (2005) Quantitative analysis of ubiquitin-immunoreactivity in
the midbrain periaqueductal gray matter with regard to the cause
of death in forensic autopsy. Leg Med (Tokyo) 7:151–156
66. Ishikawa T, Zhu BL, Li DR, Zhao D, Michiue T, Maeda H (2007)
Immunohistochemical investigation of ubiquitin and myoglobin
in the kidney in medicolegal autopsy cases. Forensic Sci Int
171:136–141
Int J Legal Med (2013) 127:93–102 101
67. Smith HJ, Khal J, Tisdale MJ (2005) Downregulation of
ubiquitin-dependent protein degradation in murine myotubes
during hyperthermia by eicosa pentaenoic acid. Biochem
Biophys Res Commun 332:83–88
68. Ishikawa T, Quan L, Li DR, Zhao D, Michiue T, Hamel M,
Maeda H (2008) Postmortem biochemistry and immunohisto-
chemistry of adrenocorticotropic hormone with special regard to
fatal hypothermia. Forensic Sci Int 179:147–151
69. Ishikawa T, Yoshida C, Michiue T, Perdekamp MG, Pollak S,
Maeda H (2010) Immunohistochemistry of catecholamines in the
hypothalamic-pituitary-adrenal system with special regard to fatal
hypothermia and hyperthermia. Leg Med (Tokyo) 12:121–127
70. Yoshida C, Ishikawa T, Michiue T, Quan L, Maeda H (2011)
Postmortem biochemistry and immunohistochemistry of chro-
mogranin A as a stress marker with special regard to fatal hypo-
thermia and hyperthermia. Int J Legal Med 125:11–20
71. Maeda H, Ishikawa T, Michiue T (2011) Forensic biochemistry for
functional investigation of death: concept and practical application.
Leg Med (Tokyo) 13:55–67
72. Palmiere C, Mangin M (2011) Postmortem chemistry update part
I. Int J Legal Med 126:187–198
73. Coe JI (1993) Postmortem chemistry update. Emphasis on forensic
application. Am J Forensic Med Pathol 14:91–117
74. Thierauf A, Musshoff F, Madea B (2009) Postmortem biochem-
ical investigations of vitreous humor. Forensic Sci Int 192:78–82
75. Coe JI (1969) Postmortem chemistries on human vitreous humor.
Am J Clin Pathol 51:741–750
76. Coe JI (1972) Use of chemical determinations on vitreous humor
in forensic pathology. J Forensic Sci 17:541–546
77. Coe JI (1974) Postmortem chemistry: practical considerations
and a review of the literature. J Forensic Sci 19:13–32
78. Coe JI (1977) Postmortem chemistry of blood, cerebrospinal
fluid, and vitreous humor. In: Tedeschi CG, Eckert WG,
Tedeschi LG (eds) Forensic medicine, vol 2. Saunders, Philadelphia,
pp 1030–1060
79. Coe JI (1977) Postmortem chemistry of blood, cerebrospinal
fluid, and vitreous humor. Leg Med Annu 1976:55–92
80. Ingham AI, Byard RW (2009) The potential significance of
elevated vitreous sodium levels at autopsy. J Forensic Leg Med
16:437–440
81. Li DR, Quan L, Zhu BL, Ishikawa T, Michiue T, Zhao D, Yoshida
C, Chen JH, Wang Q, Komatsu A, Azuma Y, Maeda H (2009)
Evaluation of postmortem calcium and magnesium levels in the
pericardial fluid with regard to the cause of death in medicolegal
autopsy. Leg Med (Tokyo) 11:S276–S278
82. Kortelainen ML, Huttunen P, Lipinlampi T (1990) Urinary cat-
echolamines in hyperthermia-related deaths. Forensic Sci Int
48:103–110
83. Zhu BL, Ishikawa T, Michiue T, Li DR, Zhao D, Quan L, Oritani S,
Bessho Y,Maeda H (2007) Postmortem serum catecholamine levels
in relation to the cause of death. Forensic Sci Int 173:122–129
84. Ishikawa T, Michiue T, Maeda H (2011) Evaluation of postmor-
tem serum and cerebrospinal fluid growth hormone levels in
relation to the cause of death in forensic autopsy. Hum Cell
24:74–77
85. Zhu BL, Ishida K, Quan L, Taniguchi M, Oritani S, Li DR, Fujita
MQ, Maeda H (2002) Postmortem serum uric acid and creatinine
levels in relation to the causes of death. Forensic Sci Int 125:59–66
86. Zhu BL, Ishikawa T, Michiue T, Li DR, Zhao D, Quan L, Maeda
H (2005) Evaluation of postmortem urea nitrogen, creatinine and
uric acid levels in pericardial fluid in forensic autopsy. Leg Med
(Tokyo) 7:287–292
87. Zhu BL, Ishikawa T, Michiue T, Tanaka S, Zhao D, Li DR, Quan L,
Oritani S, Maeda H (2007) Differences in postmortem urea nitro-
gen, creatinine and uric acid levels between blood and pericardial
fluid in acute death. Leg Med (Tokyo) 9:115–122
88. Zhu BL, Ishikawa T, Michiue T, Li DR, Zhao D, Oritani S,
Kamikodai Y, Tsuda K, Okazaki S, Maeda H (2006) Postmortem
cardiac troponin T levels in the blood and pericardial fluid. Part 1.
Analysis with special regard to traumatic causes of death. Leg Med
(Tokyo) 8:86–93
89. Zhu BL, Ishikawa T, Michiue T, Li DR, Zhao D, Kamikodai Y,
Tsuda K, Okazaki S, Maeda H (2006) Postmortem cardiac troponin
T levels in the blood and pericardial fluid. Part 2: analysis for
application in the diagnosis of sudden cardiac death with regard to
pathology. Leg Med (Tokyo) 8:94–101
90. Zhu BL, Ishikawa T, Michiue T, Li DR, Zhao D, Tanaka S,
Kamikodai Y, Tsuda K, Okazaki S, Maeda H (2007)
Postmortem pericardial natriuretic peptides as markers of cardiac
function in medico-legal autopsies. Int J Legal Med 121:28–35
91. Zhu BL, Ishikawa T, Michiue T, Li DR, Zhao D, Bessho Y,
Kamikodai Y, Tsuda K, Okazaki S, Maeda H (2007)
Postmortem cardiac troponin I and creatine kinase MB levels in
the blood and pericardial fluid as markers of myocardial damage
in medicolegal autopsy. Leg Med (Tokyo) 9:241–250
92. Wang Q, Michiue T, Ishikawa T, Zhu BL, Maeda H (2011)
Combined analyses of creatine kinase MB, cardiac troponin I
and myoglobin in pericardial and cerebrospinal fluids to investigate
myocardial and skeletal muscle injury in medico-legal autopsy
cases. Leg Med (Tokyo) 13:226–232
93. Quan L, Ishikawa T, Hara J, Michiue T, Chen JH, Wang Q, Zhu
BL, Maeda H (2011) Postmortem serotonin levels in cerebrospinal
and pericardial fluids with regard to the cause of death in medico-
legal autopsy. Leg Med (Tokyo) 13:75–78
94. Li DR, Michiue T, Zhu BL, Ishikawa T, Quan L, Zhao D, Yoshida
C, Chen JH, Wang Q, Komatsu A, Azuma Y, Maeda H (2009)
Evaluation of postmortem S100B levels in the cerebrospinal fluid
with regard to the cause of death in medicolegal autopsy. Leg
Med (Tokyo) 11:S273–S275
95. Fujita MQ, Zhu BL, Ishida K, Quan L, Oritani S, Maeda H
(2002) Serum C-reactive protein levels in postmortem blood–an
analysis with special reference to the cause of death and survival
time. Forensic Sci Int 130(2–3):160–166
96. Maeda H, Zhu BL, Bessho Y, Ishikawa T, Quan L, Michiue T,
Zhao D, Li DR, Komatsu A (2008) Postmortem serum nitrogen
compounds and C-reactive protein levels with special regard to
investigation of fatal hyperthermia. Forensic Sci Med Pathol
4:175–180
97. Ishikawa T, Hamel M, Zhu BL, Li DR, Zhao D, Michiue T,
Maeda H (2008) Comparative evaluation of postmortem serum
concentrations of neopterin and C-reactive protein. Forensic Sci
Int 179:135–143
98. Nishio H, Suzuki K (2005) Three cases of suspected hyperthermia
with remarkable elevation of serum mast cell tryptase. Forensic Sci
Int 149:51–55
99. Zhu BL, Ishida K, Quan L, Taniguchi M, Oritani S, Kamikodai Y,
Fujita MQ, Maeda H (2001) Post-mortem urinary myoglobin
levels with reference to the cause of death. Forensic Sci Int
115:183–188
100. Nylén ES, Al Arifi A, Becker KL, Snider RH Jr, Alzeer A (1997)
Effect of classic heatstroke on serum procalcitonin. Crit Care
Med 25:1362–1365
101. Oberhoffer M, Karzai W, Meier-Hellmann A, Reinhart K (1998)
Procalcitonin. A new diagnostic parameter for severe infections
and sepsis. Anaesthesist 47:581–587
102. Hausfater P, Hurtado M, Pease S, Juillien G, Lvovschi VE,
Salehabadi S, Lidove O, Wollf M, Bernard M, Chollet-Martin
S, Riou B (2008) Is procalcitonine a marker of critical illness in
heatstroke? Intensive Care Med 34:1377–1383
103. Tong HS, Liu YS, Wen Q, Tang YQ, Yuan FF, Su L (2012)
Serum procalcitonin predicting mortality in exertional heatstroke.
Emerg Med J 29:113–117
102 Int J Legal Med (2013) 127:93–102
